Analysis of apolipoprotein e, α1-antichymotrypsin and presenilin-1 genes polymorphisms in dementia caused by normal pressure hydrocephalus in man

Neuroscience Letters

Volumn 229, Issue 3, 1997, Pages 177-180

  Nacmias, Benedetta ^a   Tedde, Andrea ^a   Guarnieri, Bianca Maria ^b   Petruzzi, Concetta ^b   Ortenzi, Luigi ^b   Serio, Antonio ^b   Amaducci, Luigi ^a   Sorbi, Sandro ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Casa di Cura 'Villa Serena'   (Italy)

Author keywords

1 Antichymotrypsin genetics; Apolipoprotein E; Normal pressure hydrocephalus; Polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; PRESENILIN 1;

ADULT; AGED; AGING; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; GAIT DISORDER; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; LIPOPROTEIN SECRETION; MALE; NORMOTENSIVE HYDROCEPHALUS; ONSET AGE; PRIORITY JOURNAL; URINE INCONTINENCE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALPHA 1-ANTICHYMOTRYPSIN; APOLIPOPROTEINS E; DEMENTIA; FEMALE; GENOTYPE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, GENETIC; PRESENILIN-1; PROGNOSIS;

EID: 0030742447     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00449-7     Document Type: Article

References (17)

1. Adams R.D., Fisher C.M., Hakim S., Ojemann R.G., Sweet W.H. Symptomatic occult hydrocephalus with 'normal' cerebrospinal fluid pressure. A treatable syndrome. N. Engl. J. Med. 273:1965;117-126.
2. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskel P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
3. El Gammal T.E., Allen M.B., Brooks B.S., Mark E.K. MR evaluation of hydrocephalus. Am. J. Neurosci. Res. 8:1987;591-597.
4. Foltz E.L., Ward A.A. Communicating hydrocephalus from subarachnoid bleeding. J. Neurosurg. 13:1956;546-548.
5. Greitz T.V.B., Grepe A.O.L., Kalmar M.S.F. Pre and post-operative evaluation of cerebral blood flow in low-pressure hydrocephalus. J. Neurosurg. 31:1969;644-651.
6. Hakim S., Adams R.D. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J. Neurol. Sci. 2:1965;307-327.
7. Helisalmi S., Linnaranta K., Lehtovirta M., Mannermaa A., Heinonen O., Ryynanen M., Riekkinen P., Soininen H. Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci. Lett. 205:1996;61-64.
8. Jack C.R., Mokri B., Laws E.R., Houser O.W., Baker H.L., Petersen R.C. MR findings in normal-pressure hydrocephalus: significance and comparison with other forms of dementia. J. Comput. Assist. Tomogr. 11:1987;923-931.
9. 1-antichymotrypsin polymorphism. Nat. Genet. 10:1995;486-488.
10. 1-antichymotrypsin polymorphism in Alzheimer's disease. Ann. Neurol. 40:1996;678-680.
11. Pickering-Brown S.M., Mann D.M.A., Bourke J.P., Roberts D.A., Balderson D., Burns A., Byrne J., Owen F. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and other β-amyloid-forming diseases. Lancet. 343:1994;1155.
12. Saunders A.M., Schmader K., Breitner J.C.S., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., Schmechel D.E., Strittmatter W.J., Pericak-Vance M.A., Roses A.D. Apolipoprotein E ε4 allele distribution in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 342:1993;710-711.
13. Schneider J.A., Gearing M., Robbins R.S., de l'Aune W., Mirra S.S. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann. Neurol. 38:1995;131-135.
14. Sorbi, S., Nacmias, B., Forleo, P., Latorraca, S., Gobbini, I., Bracco, L., Piacentini, S. and Amaducci, L., ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease, Neurosci. Lett. 177 (1994) 100-102.
15. Sorbi S., Nacmias B., Tedde A., Forleo P., Piacentini S., Latorraca S., Amaducci L. Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease. Neurosci. Lett. 222:1997;132-134.
16. Talbot C., Houlden H., Craddock N., Crook R., Huttonn M., Lendon C., Prihar G., Morris J.C., Hardy J., Goate A. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. NeuroReport. 7:1996;534-536.
17. Wragg M., Hutton M., Talbot C., Alzheimer's Disease Collaborative Group Genetic association between intronic polymorphism in Presenilin-1 gene and late onset Alzheimer's disease. Lancet. 347:1996;509-512.